B-Cell Non-Hodgkin Lymphoma
Showing NaN - NaN of 2
B-cell Non-Hodgkin Lymphoma Trial in Worldwide (Mosunetuzumab (IV), Mosunetuzumab (SC), Polatuzumab vedotin)
Recruiting
- B-cell Non-Hodgkin Lymphoma
- Mosunetuzumab (IV)
- +4 more
-
Birmingham, Alabama
- +28 more
Jan 6, 2023
B-Cell Non-Hodgkin Lymphoma, Relapsed B-Cell Non-Hodgkin Lymphoma, Refractory B-Cell Non-Hodgkin Lymphoma Trial in Worldwide
Recruiting
- B-Cell Non-Hodgkin Lymphoma
- +2 more
- Loncastuximab Tesirine
- +4 more
-
Pembroke Pines, Florida
- +19 more
Jul 22, 2022